ICER Gives Cold Shoulder To Merck/Ridgeback’s COVID-19 Pill

 
• By Alaric DeArment
freezing
ICER's report said current evidence was inadequate to demonstrate a net health benefit for Merck/Ridgeback's Lagevrio versus symptomatic care • Source: Shutterstock

More from COVID-19

More from Scrip